Brominated furanones inhibit biofilm formation by Salmonella enterica serovar Typhimurium.
Salmonella enterica serovar Typhimurium is a main cause of bacterial food-borne diseases. As Salmonella can form biofilms in which it is better protected against antimicrobial agents on a wide diversity of surfaces, it is of interest to explore ways to inhibit biofilm formation. Brominated furanones, originally extracted from the marine alga Delisea pulchra, are known to interfere with biofilm formation in several pathogens. In this study, we have synthesized a small focused library of brominated furanones and tested their activity against S. enterica serovar Typhimurium biofilm formation. We show that several furanones inhibit Salmonella biofilm formation at non-growth-inhibiting concentrations. The most interesting compounds are (Z)-4-bromo-5-(bromomethylene)-3-alkyl-2(5H)-furanones with chain lengths of two to six carbon atoms. A microarray study was performed to analyze the gene expression profiles of Salmonella in the presence of (Z)-4-bromo-5-(bromomethylene)-3-ethyl-2(5H)-furanone. The induced genes include genes that are involved in metabolism, stress response, and drug sensitivity. Most of the repressed genes are involved in metabolism, the type III secretion system, and flagellar biosynthesis. Follow-up experiments confirmed that this furanone interferes with the synthesis of flagella by Salmonella. No evidence was found that furanones act on the currently known quorum-sensing systems in Salmonella. Interestingly, pretreatment with furanones rendered Salmonella biofilms more susceptible to antibiotic treatment. Conclusively, this work demonstrates that particular brominated furanones have potential in the prevention of biofilm formation by Salmonella serovar Typhimurium.
Janssens
Joost C A
JC
Centre of Microbial and Plant Genetics, Katholieke Universiteit Leuven, Leuven, Belgium.
Steenackers
Hans
H
Robijns
Stijn
S
Gellens
Edith
E
Levin
Jeremy
J
Zhao
Hui
H
Hermans
Kim
K
De Coster
David
D
Verhoeven
Tine L
TL
Marchal
Kathleen
K
Vanderleyden
Jos
J
De Vos
Dirk E
DE
De Keersmaecker
Sigrid C J
SC
D000900:Anti-Bacterial Agents / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology*; D018441:Biofilms / Q000187:drug effects*; D005407:Flagella / Q000187:drug effects; D005663:Furans / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology*; D020869:Gene Expression Profiling; D015964:Gene Expression Regulation, Bacterial / Q000187:drug effects; D008124:Locomotion / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D050296:Microbial Viability; D015394:Molecular Structure; D020411:Oligonucleotide Array Sequence Analysis; D012486:Salmonella typhimurium / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D005663:Furans
Nat Rev Microbiol. 2007 Jan;5(1):48-56
17143318
J Biol Chem. 1989 Dec 25;264(36):21670-6
2600086
Oral Microbiol Immunol. 2007 Oct;22(5):340-6
17803632
Appl Environ Microbiol. 2004 Aug;70(8):4941-9
15294834
Science. 1998 Apr 10;280(5361):295-8
9535661
Nat Rev Microbiol. 2008 Jun;6(6):455-65
18483484
Biomaterials. 2004 Sep;25(20):5023-30
15109864
Microbiology (Reading). 1999 Feb;145 ( Pt 2):283-291
10075410
Can J Vet Res. 2002 Apr;66(2):86-92
11989739
Nature. 2002 Jan 31;415(6871):545-9
11823863
J Infect Dis. 2005 Jun 1;191(11):1881-8
15871122
Microbiology (Reading). 2001 Sep;147(Pt 9):2517-2528
11535791
J Biol Chem. 2005 May 20;280(20):19563-8
15790567
Lett Appl Microbiol. 2002;34(4):293-9
11940163
J Bacteriol. 2004 Feb;186(3):692-8
14729694
Biotechnol Bioeng. 2004 Dec 5;88(5):630-42
15470704
FEMS Microbiol Lett. 2001 Nov 27;205(1):131-8
11728727
Prog Mol Subcell Biol. 2006;42:55-86
16805438
Annu Rev Genet. 2001;35:439-68
11700290
EMBO Rep. 2007 Jul;8(7):616-21
17603533
Appl Environ Microbiol. 2007 Jan;73(2):535-44
17085703
J Bacteriol. 1994 Jan;176(2):269-75
8288518
Biol Proced Online. 2003;5:189-196
14615815
J Clin Invest. 2003 Nov;112(9):1300-7
14597754
Mol Microbiol. 2004 May;52(4):933-45
15130116
Mol Microbiol. 2004 Apr;52(1):169-87
15049819
Trends Microbiol. 2005 Jan;13(1):27-33
15639629
Mol Cell. 2004 Sep 10;15(5):677-87
15350213
Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1639-44
9990077
Mol Microbiol. 2003 Nov;50(4):1411-27
14622426
Infect Immun. 2002 May;70(5):2640-9
11953406
Environ Microbiol. 2001 Nov;3(11):731-6
11846763
Arch Microbiol. 1977 Feb 4;112(1):73-9
843170
Nat Rev Microbiol. 2004 Feb;2(2):95-108
15040259
FEMS Microbiol Rev. 2004 Jun;28(3):261-89
15449604
Annu Rev Cell Dev Biol. 2005;21:319-46
16212498
J Antimicrob Chemother. 2001 Jul;48 Suppl 1:5-16
11420333
J Bacteriol. 2003 Feb;185(4):1357-66
12562806
Nature. 1981 May 21;291(5812):238-9
7015147
EMBO J. 2003 Aug 1;22(15):3803-15
12881415
Appl Environ Microbiol. 2006 Sep;72(9):6419-23
16957276
BMC Microbiol. 2004 Jul 02;4:25
15233843
J Bacteriol. 2007 Jul;189(13):4587-96
17483226
FEMS Microbiol Lett. 2007 Feb;267(2):200-6
17156099
Microbiology (Reading). 2002 Apr;148(Pt 4):1119-1127
11932456
J Bacteriol. 1996 Nov;178(22):6618-22
8932319
Mol Microbiol. 1996 Oct;22(2):367-78
8930920
Microbiology (Reading). 2006 Nov;152(Pt 11):3411-3424
17074910
J Bacteriol. 1998 Mar;180(5):1185-93
9495757
Microbiology (Reading). 2002 Jan;148(Pt 1):87-102
11782502
J Bacteriol. 2001 Oct;183(19):5733-42
11544237
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
11309499
Environ Microbiol. 2007 Oct;9(10):2486-95
17803774
Philos Trans R Soc Lond B Biol Sci. 2007 Jul 29;362(1483):1119-34
17360280
Mol Microbiol. 2001 Nov;42(3):777-93
11722742
Appl Environ Microbiol. 2000 May;66(5):2079-84
10788385
Curr Opin Investig Drugs. 2005 Feb;6(2):178-84
15751741
Nat Rev Drug Discov. 2003 Feb;2(2):114-22
12563302
Microbiology (Reading). 2000 Dec;146 Pt 12:3237-3244
11101681
Mol Microbiol. 2003 Aug;49(3):581-90
12864845
Environ Microbiol. 2002 Jan;4(1):18-28
11966822
Sci Prog. 2006;89(Pt 3-4):167-211
17338438
Appl Environ Microbiol. 1996 Nov;62(11):4284-7
16535454